コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 (14.3%) transaminase elevation, and 1 (4.8%) ischemic optic neuropathy.
2 ubjects and in patients with papilledema and ischemic optic neuropathy.
3 primary lesion, is an important factor after ischemic optic neuropathy.
4 ferentiate from optic neuritis and arteritic ischemic optic neuropathy.
5 ior ischemic optic neuropathy, and posterior ischemic optic neuropathy.
6 t visual loss, Takayasu retinopathy (TR), or ischemic optic neuropathy.
8 vo retinal changes following murine anterior ischemic optic neuropathy (AION) by using spectral-domai
9 decreased vision and present a rare anterior ischemic optic neuropathy (AION) case in a patient with
11 erein we report a case of bilateral anterior ischemic optic neuropathy (AION) showing histopathologic
12 aculopathy (PAMM) in the setting of anterior ischemic optic neuropathy (AION) to distinguish arteriti
13 were compared: 30 normals, 20 with anterior ischemic optic neuropathy (AION), and 25 with papilledem
14 the retina and optic nerve (ON) in anterior ischemic optic neuropathy (AION), using a c-fos transgen
15 diagnosed optic neuropathy (n = 17, anterior ischemic optic neuropathy [AION]; n = 5, compressive opt
16 ow the clinician to more accurately diagnose ischemic optic neuropathies and counsel the patient with
17 of these were misdiagnosed as glaucoma (two ischemic optic neuropathies and two congenital optic dis
18 and pathophysiology of nonarteritic anterior ischemic optic neuropathy and aid in developing new stra
19 pment and progression of nonarteric anterior ischemic optic neuropathy and glaucomatous optic neuropa
21 ntly identified risk factors associated with ischemic optic neuropathy and prone spinal fusion surger
22 d as mild or moderate in severity), 1 (0.1%) ischemic optic neuropathy, and 1 (0.1%) infectious endop
23 Two of the patients had glaucoma, one had ischemic optic neuropathy, and one had unilateral optic
24 schemic optic neuropathy, arteritic anterior ischemic optic neuropathy, and posterior ischemic optic
25 optic nerve damage in nonarteritic anterior ischemic optic neuropathy appears to result from a perfu
26 able treatment options for demyelinating and ischemic optic neuropathies are ineffective and can even
27 hese disorders include nonarteritic anterior ischemic optic neuropathy, arteritic anterior ischemic o
28 sociated indicator for nonarteritic anterior ischemic optic neuropathy as well as for retinal vascula
29 rategies aimed at modifying risk factors for ischemic optic neuropathy associated with prone spinal f
30 es, ischemic optic neuropathy (with anterior ischemic optic neuropathy being the most common form), a
31 ch as the Optic Neuritis Treatment Trial and Ischemic Optic Neuropathy Decompression Trial, have prov
34 variability might make nonarteritic anterior ischemic optic neuropathy hard to differentiate from opt
35 Hypertensive optic neuropathy, a variant of ischemic optic neuropathy, has delayed onset compared wi
36 ociated with prone spinal fusion surgery and ischemic optic neuropathy identified in a large multicen
37 aglutide showed significantly higher odds of ischemic optic neuropathy (ION) (FAERS: ROR = 11.12, 95%
39 reports have demonstrated the occurrence of ischemic optic neuropathy (ION) following intravitreal i
40 udy seeks to determine the risk of NAION and ischemic optic neuropathy (ION) in patients prescribed G
44 dema (CME; n = 3), and nonarteritic anterior ischemic optic neuropathy (n = 1) in the repositioning g
45 hemic syndrome (OIS), non-arteritic anterior ischemic optic neuropathy (NA-AION) and amaurosis fugax
46 oversial management of nonarteritic anterior ischemic optic neuropathy (NA-AION) and central retinal
49 , optic neuritis (14), nonarteritic anterior ischemic optic neuropathy (NAION) (21), and ONH swelling
50 he association between nonarteritic anterior ischemic optic neuropathy (NAION) and an increased risk
51 ar case of concurrent non-arteritic anterior ischemic optic neuropathy (NAION) and cilioretinal arter
52 coherence tomography (OCT) scans in anterior ischemic optic neuropathy (NAION) and demyelinating opti
53 OSAS) in patients with nonarteritic anterior ischemic optic neuropathy (NAION) and its influence on s
54 of patients with acute nonarteritic anterior ischemic optic neuropathy (NAION) and normal age-related
55 mpare the mechanism of PVD and non-arteritic ischemic optic neuropathy (NAION) at the same time in di
56 ures that distinguish non-arteritic anterior ischemic optic neuropathy (NAION) from papilledema, we h
57 the rate and risk of non-arteritic anterior ischemic optic neuropathy (NAION) in adults receiving se
61 The pathophysiology of nonarteritic anterior ischemic optic neuropathy (NAION) is not completely unde
63 tudies have shown that nonarteritic anterior ischemic optic neuropathy (NAION) is uncommon in persons
67 ts with a diagnosis of nonarteritic anterior ischemic optic neuropathy (NAION) seen in the Wilmer Eye
68 have a greater risk of nonarteritic anterior ischemic optic neuropathy (NAION) than nondiabetic patie
69 who suffer unilateral non-arteritic anterior ischemic optic neuropathy (NAION) will eventually develo
70 udotumor cerebri), (3) nonarteritic anterior ischemic optic neuropathy (NAION), (4) optic nerve head
71 l hypertension (IIH), non-arteritic anterior ischemic optic neuropathy (NAION), and healthy eyes.
72 by optic neuritis and nonarteritic anterior ischemic optic neuropathy (NAION), conditions without in
73 five groups: normal, glaucoma, nonarteritic ischemic optic neuropathy (NAION), treated proliferative
74 ies have provided evidence that non-arterial ischemic optic neuropathy (NAION), vitreous traction, an
81 tio, 11.61; 95% CI, 1.34-100.56; P = .03) or ischemic optic neuropathy (odds ratio, 5.27; 95% CI, 1.6
82 r and retrobulbar arteritic and nonarteritic ischemic optic neuropathy, optic neuritis, Cuban epidemi
83 ro-ophthalmic conditions, including anterior ischemic optic neuropathy, optic neuritis/multiple scler
85 led, 27 with NTG and 54 with NGON, including ischemic optic neuropathy, previous optic neuritis, and
88 tudy, we examined 118 patients with anterior ischemic optic neuropathy referred to a tertiary care ce
89 ion in the clinical records of patients with ischemic optic neuropathy referred to Rasoul Akram Hospi
92 fects of diabetes contribute to nonarteritic ischemic optic neuropathy, vasculopathic cranial neuropa
94 nfectious conditions, post-traumatic causes, ischemic optic neuropathy (with anterior ischemic optic